WO2024201344 - COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND CHIMERIC ANTIGEN RECEPTOR (CAR)-IMMUNE CELLS
National phase entry is expected:
Publication Number
WO/2024/201344
Publication Date
03.10.2024
International Application No.
PCT/IB2024/052992
International Filing Date
27.03.2024
Title **
[English]
COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND CHIMERIC ANTIGEN RECEPTOR (CAR)-IMMUNE CELLS
[French]
COMPOSITIONS, SYSTÈMES ET MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE DE CHAMPS DE TRAITEMENT DE TUMEUR ET DE CELLULES IMMUNITAIRES À RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES (CAR)
Applicants **
NOVOCURE GMBH
6 Park
6039 Root D4, CH
Inventors
VOLOSHIN-SELA, Tali
c/o Novocure GmbH, Topaz Building, 4th Floor
MATAM Center, P.O. Box 15022, Sha'ar HaCarmel
31905 Haifa, IL
KAN, Tal
c/o Novocure GmbH, Topaz Building, 4th Floor
MATAM Center, P.O. Box 15022, Sha'ar HaCarmel
31905 Haifa, IL
BARSHESHET, Yiftah
c/o Novocure GmbH, Topaz Building, 4th Floor
MATAM Center, P.O. Box 15022, Sha'ar HaCarmel
31905 Haifa, IL
AVIGDOR, Lilach
c/o Novocure GmbH, Topaz Building, 4th Floor
MATAM Center, P.O. Box 15022, Sha'ar HaCarmel
31905 Haifa, IL
Priority Data
63/493,131
30.03.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1493 | |
| EPO | Filing, Examination | 9285 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 6835 |
Total: 18719 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Compositions, systems, and methods for reducing viability of cancer cells and treating cancer, as well as preventing an increase of volume of a tumor present in a body of a living subject, are disclosed. The systems and methods involve application of an alternating field concurrently with administration of at least one composition comprising at least one chimeric antigen receptor (CAR)-immune cell.[French]
Sont ici divulgués des compositions, des systèmes et des méthodes pour réduire la viabilité de cellules cancéreuses et traiter le cancer, ainsi que pour prévenir une augmentation du volume d'une tumeur présente dans le corps d'un sujet vivant. Les systèmes et les méthodes impliquent l'application d'un champ alternatif simultanément avec l'administration d'au moins une composition comprenant au moins une cellule immunitaire à récepteurs antigéniques chimériques (CAR).